SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health by Magdalena Madero, Glenn M. Chertow, Patrick B. Mark

Get full text

Chronic kidney disease in older adults: challenges and opportunities for the primary care provider by Brian M. Brady, Jo-Anne Suffoletto, Richard Sankary, Glenn M. Chertow

Get full text

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Active Kidney Involvement in the United States: 2016–2020 by Jianling Tao, Sai Liu, Maria Montez-Rath, Vivek Charu, Glenn M. Chertow

Get full text

Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults by Ogo Egbuna, Vincent Audard, George Manos, Simon Tian, Fanuel Hagos, Glenn M. Chertow

Get full text

Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity by Susan L. Ziolkowski, Jin Long, Joshua F. Baker, Glenn M. Chertow, Mary B. Leonard

Get full text

Patient Perspectives on Using Telemedicine During In-Center Hemodialysis: A Qualitative Study by Trenton M. Haltom, Susie Q. Lew, Wolfgang C. Winkelmayer, Glenn M. Chertow, Allison Jaure, Kevin F. Erickson

Get full text

Hypocitraturia and Risk of Bone Disease in Patients With Kidney Stone Disease by Calyani Ganesan, I‐Chun Thomas, Maria E Montez‐Rath, Glenn M Chertow, John T Leppert, Alan C Pao

Get full text

The Use of Telemedicine by US Nephrologists for In-Center Hemodialysis Care During the Pandemic: An Analysis of National Medicare Claims by Jingbo Niu, Omar Rosales, Abiodun Oluyomi, Susie Q. Lew, Wolfgang C. Winkelmayer, Glenn M. Chertow, Kevin F. Erickson

Get full text

Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists by Anjay Rastogi, Ashté Collins, Ellie Kelepouris, Wayne Kotzker, John P. Middleton, Minesh Rajpal, Prabir Roy-Chaudhury, Glenn M. Chertow

Get full text

Declining Rates of Inpatient Parathyroidectomy for Primary Hyperparathyroidism in the US. by Sun Moon Kim, Aimee D Shu, Jin Long, Maria E Montez-Rath, Mary B Leonard, Jeffrey A Norton, Glenn M Chertow

Get full text

Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S. by Shuchi Anand, Maria E Montez-Rath, Jialin Han, Pablo Garcia, Julie Bozeman, Russell Kerschmann, Paul Beyer, Julie Parsonnet, Glenn M Chertow

Get full text

Hyperkalemia and the Risks of Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease by Abiy Agiro, Fan Mu, Erin Cook, Alexandra Greatsinger, Jingyi Chen, Angela Zhao, Elaine Louden, Ellen Colman, Pooja Desai, Glenn M. Chertow

Get full text

Vascular Access for Home Hemodialysis: A Perspective on Tunneled Central Venous Catheters at Home by Michael Alexander Aragon, Osama El Shamy, Sijie Zheng, Glenn M. Chertow, Joel Glickman, Eric Weinhandl, Paul Komenda, Stephan Dunning, Frank Liu, Charmaine Lok

Get full text

Association of Apolipoprotein L-1 polymorphisms with blood pressure in three multi-ethnic African studies by Shuchi Anand, Safa Abdalla, Gladwell Gathecha, Olulola O Oladapo, Kibachio Joseph, Maria E Montez-Rath, Marcella Aslan, Michele Barry, Glenn M Chertow, Charles Rotimi, David J Friedman

Get full text

Effects of Dapagliflozin in Patients with Membranous Nephropathy by Glenn M. Chertow, Hiddo Lambers Heerspink, Patrick B. Mark, Jamie P. Dwyer, Michal Nowicki, David C. Wheeler, Ricardo Correa-Rotter, Peter Rossing, Robert D. Toto, Anna Maria Langkilde, Niels Jongs

Get full text

Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification by Joan Perelló, Joan Perelló, Joan Alberti, Juan Vicente Torres, Miguel D. Ferrer, Miguel D. Ferrer, M. Mar Perez, Firas Bassissi, Alex Gold, Alex Gold, Paolo Raggi, Glenn M. Chertow, Carolina Salcedo

Get full text

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial by Glenn M. Chertow, Ricardo Correa‐Rotter, Priya Vart, Niels Jongs, John J. V. McMurray, Peter Rossing, Anna Maria Langkilde, C. David Sjöström, Robert D. Toto, David C. Wheeler, Hiddo J. L. Heerspink

Get full text

Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure by Jean‐Claude Tardif, Jean Rouleau, Glenn M. Chertow, Ayman Al‐Shurbaji, Vera Lisovskaja, Stephanie Gustavson, Yanli Zhao, Nadia Bouabdallaoui, Akshay S. Desai, Alexander Chernyavskiy, Maria Evsina, Béla Merkely, John J.V. McMurray, Marc A. Pfeffer

Get full text

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extensionResearch in context by Smeeta Sinha, Sagar U. Nigwekar, Vincent Brandenburg, Lisa J. Gould, Thomas E. Serena, Sharon M. Moe, George R. Aronoff, Dinesh K. Chatoth, Jeffrey L. Hymes, Kevin J. Carroll, Gabriela Alperovich, Laurence H. Keller, Joan Perelló, Alex Gold, Glenn M. Chertow

Get full text

Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA‐CKD by Carlo Briguori, Roy O. Mathew, Zhen Huang, Kreton Mavromatis, LaTonya J. Hickson, Wei Ling Lau, Anoop Mathew, Sandeep Mahajan, David C. Wheeler, Kathleen J. Claes, Gang Chen, Fernando E. B. Nolasco, Gregg W. Stone, Jerome L. Fleg, Mandeep S. Sidhu, Frank W. Rockhold, Glenn M. Chertow, Judith S. Hochman, David J. Maron, Sripal Bangalore

Get full text